<DOC>
	<DOC>NCT01302275</DOC>
	<brief_summary>The purpose of this trial is to determine if the effect of oxcarbazepine on chronic peripheral nerve pain depends on the supposed mechanism of the pain, ie. if oxcarbazepine mainly relieve pain in patients with irritable nerves.</brief_summary>
	<brief_title>Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Neuralgia, Postherpetic</mesh_term>
	<mesh_term>Peripheral Nerve Injuries</mesh_term>
	<mesh_term>Oxcarbazepine</mesh_term>
	<mesh_term>Carbamazepine</mesh_term>
	<criteria>age &gt; 18 years old definite or probable neuropathic pain diagnosis of polyneuropathy, postherpetic neuralgia or peripheral nerve inju pain duration &gt; 3 months pain rating at baseline &gt;= 4 point NRS Informed consent other nonneuropathic pain condition allergy to oxcarbazepine renal or hepatic impairment epilepsy depression and other serious psychiatric disorders serious medical condition previous treatment for neuropathic that cannot be stopped pregnancy patients expected not to be able to comply with study protocol treatment with anticonvulsants, antidepressant or opioids</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>neuropathic pain</keyword>
	<keyword>oxcarbazepine</keyword>
	<keyword>pain mechanism</keyword>
</DOC>